Gilberto Lopes

Dr. Gilberto Lopes, a thoracic medical oncologist from the Sylvester Cancer Center, dives into the world of EGFR inhibitors like Afatinib and Osimertinib. He discusses the evolution of these therapies and highlights common side effects, including skin toxicity and diarrhea. Strategies for managing these toxicities are shared to improve patient quality of life. Insights from recent studies reveal new combinations that enhance treatment effects, while emphasizing the importance of proactive care to optimize outcomes.